A previous meta-analysis using patients with COVID-19 reported that proportions of leukocytosis, lymphopenia, and elevated CRP levels were 17%, 43%, and 58%, respectively31, while those in our study were 36%, 43%, and 48%. This evidence concerns the gene CRP and lymphopenia.